FDA requests more data on MedImmune liquid FluMist

07/19/2006 | Washington Post (tiered subscription model), The

The FDA requires more information from MedImmune about the liquid version of its inhaled FluMist flu vaccine, the company says, adding it does not expect a delay in approval. A spokeswoman said the agency has requested technical clarification of submitted clinical and testing data.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide